Published in J Biol Chem on December 19, 1997
Role of sphingolipids in microbial pathogenesis. Infect Immun (2006) 1.27
Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. Clin Microbiol Rev (1999) 1.21
Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans. Antimicrob Agents Chemother (2004) 1.20
Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans. Antimicrob Agents Chemother (2005) 1.09
Characterization of inositol phosphorylceramides from Leishmania major by tandem mass spectrometry with electrospray ionization. J Am Soc Mass Spectrom (2007) 1.04
Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi. Biochem J (2005) 0.96
Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A. Antimicrob Agents Chemother (2008) 0.79
Sphingolipid and ceramide homeostasis: potential therapeutic targets. Biochem Res Int (2012) 0.77
The synthetic amphipathic peptidomimetic LTX109 is a potent fungicide that disturbs plasma membrane integrity in a sphingolipid dependent manner. PLoS One (2013) 0.76
A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem (1997) 9.97
A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature (1992) 9.96
Integrative transformation of Candida albicans, using a cloned Candida ADE2 gene. Mol Cell Biol (1986) 4.30
Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (1997) 4.14
Synthesis and antifungal activity of novel cationic pneumocandin B(o) derivatives. J Med Chem (1994) 3.52
Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies. Infect Immun (1996) 3.08
Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob Agents Chemother (1994) 2.99
Directed mutagenesis in Candida albicans: one-step gene disruption to isolate ura3 mutants. Mol Cell Biol (1987) 2.71
Primary sequence and immunological characterization of beta-subunit of high conductance Ca(2+)-activated K+ channel from smooth muscle. J Biol Chem (1994) 2.62
The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother (2002) 2.60
Development of autonomously replicating plasmids for Candida albicans. Mol Cell Biol (1987) 2.58
Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum (2006) 2.57
Tremorgenic indole alkaloids potently inhibit smooth muscle high-conductance calcium-activated potassium channels. Biochemistry (1994) 2.51
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. J Pharmacol Exp Ther (2004) 2.42
A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase. J Bacteriol (1994) 2.33
Substandard and falsified anti-tuberculosis drugs: a preliminary field analysis. Int J Tuberc Lung Dis (2013) 2.11
Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom. Biochemistry (1994) 1.97
Molecular mechanism of hypoxia-inducible factor 1alpha -p300 interaction. A leucine-rich interface regulated by a single cysteine. J Biol Chem (2000) 1.93
Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics (1985) 1.92
Subunit composition of the high conductance calcium-activated potassium channel from smooth muscle, a representative of the mSlo and slowpoke family of potassium channels. J Biol Chem (1994) 1.89
Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response. Proc Natl Acad Sci U S A (1998) 1.72
UDP-N-acetylglucosamine acyltransferase of Escherichia coli. The first step of endotoxin biosynthesis is thermodynamically unfavorable. J Biol Chem (1993) 1.72
Patient participation. J R Coll Gen Pract (1980) 1.70
Use of toxins to study potassium channels. J Bioenerg Biomembr (1991) 1.70
Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother (2000) 1.66
Purification and characterization of the conidial laccase of Aspergillus nidulans. J Bacteriol (1982) 1.56
Mosaicism for deletion 17p11.2 in a boy with the Smith-Magenis syndrome. Am J Med Genet (1993) 1.47
Temperature-shift analysis of conidial development in Aspergillus nidulans. Dev Biol (1982) 1.46
Cloning and characterization of the plasma membrane H(+)-ATPase from Candida albicans. J Bacteriol (1991) 1.40
Histologic subclassification of the cystadenolymphoma of the parotid gland. Analysis of 275 cases. Virchows Arch A Pathol Anat Histol (1980) 1.40
Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422. Mol Pharmacol (1984) 1.38
Sphingofungins E and F: novel serinepalmitoyl transferase inhibitors from Paecilomyces variotii. J Antibiot (Tokyo) (1992) 1.36
Urology in a modern health centre. Br Med J (1975) 1.26
Dominant spore color mutants of Aspergillus nidulans defective in germination and sexual development. J Bacteriol (1981) 1.24
The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity. J Antibiot (Tokyo) (1995) 1.23
Purification of angiotensin-converting enzyme from rabbit lung and human plasma by affinity chromatography. J Biol Chem (1985) 1.22
Functional reconstitution of the large-conductance, calcium-activated potassium channel purified from bovine aortic smooth muscle. Biochemistry (1995) 1.20
Molecular cloning and characterization of a lipid phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death. Proc Natl Acad Sci U S A (2000) 1.19
How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines? Br J Pharmacol (2011) 1.19
Preservation of olfaction in anterior craniofacial approaches. J Neurosurg (1993) 1.18
Synthetic charybdotoxin-iberiotoxin chimeric peptides define toxin binding sites on calcium-activated and voltage-dependent potassium channels. Biochemistry (1993) 1.17
The spasmodic upper-body squeeze: a characteristic behavior in Smith-Magenis syndrome. Dev Med Child Neurol (1994) 1.17
Laccase localized in hulle cells and cleistothecial primordia of Aspergillus nidulans. J Bacteriol (1983) 1.17
Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta. J Clin Invest (1994) 1.09
Genetic analysis of mutants of Aspergillus nidulans blocked at an early stage of sporulation. J Bacteriol (1984) 1.09
Molecular and catalytic properties of rabbit testicular dipeptidyl carboxypeptidase. J Biol Chem (1982) 1.03
Neurologic manifestations of the organoid nevus syndrome. Arch Neurol (1985) 1.01
One-step gene disruption by cotransformation to isolate double auxotrophs in Candida albicans. Mol Gen Genet (1988) 1.01
Mutants of Aspergillus nidulans blocked at an early stage of sporulation secrete an unusual metabolite. J Bacteriol (1984) 1.00
Isolation of an angiotensin II-binding protein from liver. Proc Natl Acad Sci U S A (1984) 0.99
Mode of delivery in the low birth weight fetus. Delivery by cesarean section independent of fetal lie versus vaginal delivery in vertex presentation. A study with long-term follow-up. Acta Obstet Gynecol Scand (1985) 0.99
Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site. J Biol Chem (1989) 0.98
Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death. Immunity (2001) 0.98
Developmental defects resulting from arginine auxotrophy in Aspergillus nidulans. J Gen Microbiol (1983) 0.98
Phosphinic acid inhibitors of D-alanyl-D-alanine ligase. J Med Chem (1988) 0.97
Induction of an apoptotic program in cell-free extracts by 2-chloro-2'-deoxyadenosine 5'-triphosphate and cytochrome c. Proc Natl Acad Sci U S A (1998) 0.97
Lymphocyte transformation in response to phytohaemagglutinin in primary biliary cirrhosis: the search for a plasma inhibitory factor. Gut (1973) 0.94
Inhibition of 3-hydroxy-3-methylglutaryl-CoA synthase and cholesterol biosynthesis by beta-lactone inhibitors and binding of these inhibitors to the enzyme. Biochem J (1993) 0.92
Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase. J Biol Chem (1998) 0.91
Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline. J Biol Chem (1985) 0.91
South Asian ethnicity and risk of childhood accidents: an ecological study at enumeration district level in Leicester. J Public Health Med (2002) 0.90
The discovery of enfumafungin, a novel antifungal compound produced by an endophytic Hormonema species biological activity and taxonomy of the producing organisms. Syst Appl Microbiol (2000) 0.89
The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1. Chem Biol (2001) 0.89
Arundifungin, a novel antifungal compound produced by fungi: biological activity and taxonomy of the producing organisms. Int Microbiol (2001) 0.88
Eye abnormalities in the Smith-Magenis contiguous gene deletion syndrome. Am J Med Genet (1993) 0.88
Precursors of the T4 internal peptides. J Virol (1977) 0.87
Inhibition of rat alpha-reductases by finasteride: evidence for isozyme differences in the mechanism of inhibition. J Steroid Biochem Mol Biol (1997) 0.86
Viridiofungins, novel inhibitors of sphingolipid synthesis. J Antibiot (Tokyo) (1997) 0.86
Concerning the mechanism of the enzymatic and nonenzymatic hydrolysis of nicotinamide nucleotide coenzymes. J Biol Chem (1978) 0.85
Evaluation of a communication course for new hearing aid users. Scand Audiol (1995) 0.84
Antimicrobial activity of viridiofungins. J Antibiot (Tokyo) (1997) 0.83
Inhibition of serine palmitoyl-transferase activity by lipoxamycin. J Antibiot (Tokyo) (1994) 0.81
[Augmentation of the extremely atrophied maxilla and mandible by autologous calvarial bone transplantation]. Mund Kiefer Gesichtschir (1999) 0.80
Intra-operative pneumatic tourniquet--perceptions of use and complications in the orthopaedic community of South Africa. S Afr Med J (1996) 0.80
Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum. J Appl Microbiol (2001) 0.80
Renin cleavage of a human kidney renin substrate analogous to human angiotensinogen, H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Ser-OH, that is human renin specific and is resistant to cathepsin D. Anal Biochem (1984) 0.80
[Clinical results of differential diagnosis of the so-called facial pain]. Zahnarztl Prax (1974) 0.80
In-vitro evaluation of the PALL Leukotrap Affinity Prion Reduction Filter as a secondary device following primary leucoreduction. Vox Sang (2005) 0.80
Mechanism-based inactivation of alanine racemase by 3-halovinylglycines. J Biol Chem (1991) 0.80
[Significance of hemodynamic parameters of blood loss in orthognathic surgery]. Mund Kiefer Gesichtschir (1999) 0.78
[Ultrastructural changes of the vagus nerve in achalasia of the esophagus]. Rev Esp Enferm Apar Dig (1977) 0.78
Restricticin, a novel glycine-containing antifungal agent. J Antibiot (Tokyo) (1991) 0.78
A nanodosimetric model of radiation-induced clustered DNA damage yields. Phys Med Biol (2010) 0.78
Late results following different methods of cleft lip repair. Cleft Palate J (1982) 0.78
Selection of peptide ligands for the antimucin core antibody C595 using phage display technology: definition of candidate epitopes for a cancer vaccine. Clin Mol Pathol (1995) 0.77